Affiliation:
1. Pusan National University
Abstract
Abstract
Background:
The overuse and misuse of antibiotics is a major public health concern, contributing to the rise of antibiotic-resistant bacteria. This study aimed to determine the prevalence of inappropriate antibiotic prescription for acute uncomplicated cystitis (AUC) in primary care clinics in Korea and identify contributing factors.
Methods:
Data from 20-64-year-old female AUC patients in the Health Insurance Review and Assessment Service-National Patient Sample were analyzed. Four categories of inappropriate antibiotic use were evaluated: inappropriate selection, duration, use of parenteral antibiotics, and multiple oral antibiotics. Multiple logistic regression was used to determine the impact of factors on inappropriate prescriptions.
Results:
Of the 3,125 patients, 2,285 (73.1%) received inappropriate antibiotics. The most common categories were the use of parenteral antibiotics. Institutional, not patient, factors, were the primary contributors to inappropriate prescription. Urology-specialized clinics had more than double the rate of inappropriate prescription compared to other clinics.
Conclusion:
More than 70% of AUC patients received inappropriate antibiotics in Korean outpatient clinics. The data highlights the urgent need for antimicrobial stewardship in the outpatient setting, with AUC as a 'high priority condition'.
Publisher
Research Square Platform LLC
Reference50 articles.
1. Definitions, classification, and clinical presentation of urinary tract infections;Johnson CC;The Medical clinics of North America,1991
2. Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 113 Suppl 1A: 5s-13s DOI 10.1016/s0002-9343(02)01054-9
3. Urinary tract infections in women;Dielubanza EJ;Medical clinics,2011
4. Urinary tract infections in women;Salvatore S;European journal of obstetrics & gynecology and reproductive biology,2011
5. Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. The American Journal of Medicine 113 (1, Supplement 1): 5–13 DOI https://doi.org/10.1016/S0002-9343(02)01054-9